Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 October 2021
EventHumanCOVID-19Vaccines
Finnish is available via eTranslation, the European Commission's machine translation service.
Translate to Finnish | Important information about machine translation
Date
- Maanantai, 25 lokakuu 2021, Koko päivä
Paikka
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary plenary meeting is organised in the context of the evaluation of an application for the use of a booster dose for the COVID-19 vaccine Spikevax.
The aim of the meeting is to conclude this evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the Agency's opinions on all questions concerning human medicines.